Cargando…
Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza
BACKGROUND: Antibody-based therapies for respiratory viruses are of increasing importance. The INSIGHT 006 trial administered anti-influenza hyperimmune intravenous immunoglobulin (Flu-IVIG) to patients hospitalized with influenza. Flu-IVIG treatment improved outcomes in patients with influenza B bu...
Autores principales: | Vanderven, Hillary A., Wentworth, Deborah N., Han, Win Min, Peck, Heidi, Barr, Ian G., Davey, Richard T., Beigel, John H., Dwyer, Dominic E., Jain, Mamta K., Angus, Brian, Brandt, Christian T., Mykietiuk, Analia, Law, Matthew G., Neaton, James D., Kent, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443807/ https://www.ncbi.nlm.nih.gov/pubmed/37289541 http://dx.doi.org/10.1172/jci.insight.167464 |
Ejemplares similares
-
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
por: Davey, Richard T, et al.
Publicado: (2019) -
Influenza-Specific Antibody-Dependent Phagocytosis
por: Ana-Sosa-Batiz, Fernanda, et al.
Publicado: (2016) -
Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody
por: Ng, Wy Ching, et al.
Publicado: (2010) -
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial
por: Ali, Shaukat, et al.
Publicado: (2021) -
Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study
por: Pett, Sarah L, et al.
Publicado: (2017)